Completed PHASE3 INTERVENTIONAL 2-arm NCT05465369

Clinical Assessment of Injectable Flowable Composite with Giomer Technology Vs High Viscosity Glass Ionomer Restorations in ART for Cancer Patients

Clinical Assessment of Injectable Flowable Composite with Giomer Based Technology Versus High Viscosity Glass Ionomer Restorations in Atraumatic Restorative Treatment (ART) for Cancer Patients (One Year Randomized Clinical Trial)

Sponsor: Cairo University

Conditions Discoloration, Tooth Fracture Tooth Secondary Caries

Interventions giomer high viscosity glass ionomer

Updated 7 times since 2022 Last updated: Sep 23, 2024 Started: Feb 7, 2023 Primary completion: May 15, 2024 Completion: May 15, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05465369, this PHASE3 trial focuses on Discoloration, Tooth and Fracture Tooth and remains completed. Sponsored by Cairo University, it has been updated 7 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Oct 2024 — Present [monthly]

Completed PHASE3

Status: Recruiting → Completed · Phase: NA → PHASE3
Sep 2024 — Oct 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2023 — Mar 2023 [monthly]

Not Yet Recruiting NA

▶ Show 2 earlier versions

Dec 2022 — Jan 2023 [monthly]

Not Yet Recruiting NA
Sep 2022 — Dec 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University
Children's Cancer Hospital Egypt 57357

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt